ap

Skip to content

Breaking News

ap: Medicare and Medicaid are denying Alzheimer’s patients like me time

FDA approved Alzheimer’s drugs should be covered by Medicare and Medicaid

Feb. 10, 2020, are another ...
FILE – In this Aug. 14, 2018 file photo, a doctor looks at a PET brain scan at the Banner Alzheimers Institute in Phoenix. Two experimental drugs failed to prevent or slow mental decline in a study of people who are virtually destined to develop Alzheimer’s disease at a relatively young age because of rare gene flaws. The results announced Monday, Feb. 10, 2020, are another disappointment for the approach that scientists have focused on for many years — trying to remove a harmful protein that builds up in the brains of people with the disease.
PUBLISHED: | UPDATED:
Getting your player ready...
Time is of the essence. Thatap why I spent some of mine this week with other Alzheimer’s Association advocates from across Colorado and neighboring states to rally outside the Denver CMS regional office. We used our precious time to call on CMS to reverse this unacceptable decision.
Already have an account Log In
This article is only available to subscribers
Flash Sale

Standard Digital

$1 for 1 year
Offer valid for non-subscribers only

RevContent Feed

More in ap Columnists